HOYA (7741) Q4 2025 earnings summary

Executive summary

• Achieved double-digit revenue growth for FY24, driven by strong IT business demand and Life Care recovery.

• Both sales and profits reached record highs, with Life Care rebounding from an IT incident and yen depreciation boosting results.

• Full-year revenue increased 13.6% to ¥866.0B, with profit before tax up 9.9% to ¥260.0B; net income attributable to owners grew 11.4% to ¥202.1B.

• Q4 FY24 revenue rose 10.1% year-over-year to ¥216.8B, driven by strong IT business, but profit before tax fell 6.1% to ¥67.7B due to FX losses.

Financial highlights

• FY24 Q4 revenue: ¥216.8B (+10% YoY, CC +11%), operating profit: ¥65.7B (+24% YoY, CC +24%), pretax profit: ¥67.7B (-6% YoY, CC -6%).

• FY24 full-year revenue: ¥866B (+14% YoY, CC +11%), operating profit: ¥255.8B (+22% YoY, CC +19%), pretax profit: ¥260B (+10% YoY, CC +7%).

• Full-year basic EPS rose to ¥581.45 from ¥515.48; equity attributable to owners per share increased to ¥2,841.73.

• Cash and cash equivalents at year-end were ¥534.0B.

• Operating cash flow for Q4 was ¥52.8B; free cash flow was ¥40.0B.

Outlook and guidance

• Plans to open ~15 new eyecity stores per year from FY25, aiming for dominant market share in Japan.

• FPD segment expects gradual recovery in demand for OLED and display-related products in FY25.

• Ongoing focus on M&A and internal development to strengthen both ophthalmology and IT business lines.

• Management notes ongoing risks from economic conditions, market trends, and currency fluctuations, with forward-looking statements subject to uncertainties.